Schaper Benz & Wise Investment Counsel’s Avanos Medical AVNS Stock Holding History

Schaper Benz & Wise Investment Counsel’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,992	Closed	-$205K	–	105
2018 Q3	$205K	Buy	+2,992	New	+$193K	0.03%	104
2015 Q3	–	Sell	-5,559	Closed	-$225K	–	96
2015 Q2	$225K	Sell	5,559 -2	-0%	-$90	0.04%	92
2015 Q1	$274K	Sell	5,561 -8,859	-61%	-$410K	0.05%	86
2014 Q4	$656K	Buy	+14,420	New	+$567K	0.13%	75

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's AVNS Position: Q4 2018 in Review

Schaper Benz & Wise Investment Counsel sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 2,992 shares — an estimated $205K sold.

Schaper Benz & Wise Investment Counsel first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $656K in Q4 2014. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Schaper Benz & Wise Investment Counsel reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
Schaper Benz & Wise Investment Counsel sold 2,992 Avanos Medical shares in Q4 2018, an estimated $205K.
Schaper Benz & Wise Investment Counsel first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
Schaper Benz & Wise Investment Counsel's Avanos Medical position peaked at $656K in Q4 2014.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q4 2018, filed 13 Feb 2019.